PLCE1 and cancer: These results support the notion that PLCε inhibitors may become promising anti-inflammatory, cancer-preventive and anti-cancer agents, and suggest that PLCε-inhibition may account for a molecular mechanism underlying the inflammation-moderating activity of zinc.